183 related articles for article (PubMed ID: 37486337)
21. Hepatitis C virus (HCV) incidence among men who have sex with men (MSM) living with HIV: results from the French Hospital Database on HIV (ANRS CO4-FHDH) cohort study, 2014 to 2017.
Castry M; Cousien A; Bellet J; Champenois K; Pialoux G; Yazdanpanah Y; Costagliola D; Grabar S; Deuffic-Burban S;
Euro Surveill; 2021 Sep; 26(38):. PubMed ID: 34558403
[TBL] [Abstract][Full Text] [Related]
22. Low prevalence of hepatitis C co-infection in recently HIV-infected minority men who have sex with men in Los Angeles: a cross-sectional study.
Chew KW; Blum ML; Javanbakht M; Clare LE; Bornfleth LD; Bolan R; Bhattacharya D; Gorbach PM
BMC Infect Dis; 2015 Nov; 15():538. PubMed ID: 26590028
[TBL] [Abstract][Full Text] [Related]
23. Determining reinfection rates by hepatitis C testing interval among key populations: A systematic review and meta-analysis.
Munari SC; Traeger MW; Menon V; Latham NH; Manoharan L; Luhmann N; Baggaley R; MacDonald V; Verster A; Siegfried N; Conway B; Klein M; Bruneau J; Stoové MA; Hellard ME; Doyle JS
Liver Int; 2023 Dec; 43(12):2625-2644. PubMed ID: 37817387
[TBL] [Abstract][Full Text] [Related]
24. All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019.
Requena MB; Protopopescu C; Stewart AC; van Santen DK; Klein MB; Jarrin I; Berenguer J; Wittkop L; Salmon D; Rauch A; Prins M; van der Valk M; Sacks-Davis R; Hellard ME; Carrieri P; Lacombe K;
Int J Drug Policy; 2024 Feb; 124():104311. PubMed ID: 38184902
[TBL] [Abstract][Full Text] [Related]
25. Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression.
Hosseini-Hooshyar S; Hajarizadeh B; Bajis S; Law M; Janjua NZ; Fierer DS; Chromy D; Rockstroh JK; Martin TCS; Ingiliz P; Hung CC; Dore GJ; Martinello M; Matthews GV
Lancet HIV; 2022 Jun; 9(6):e414-e427. PubMed ID: 35659336
[TBL] [Abstract][Full Text] [Related]
26. Impact of test-and-treat and risk reduction strategies on HCV transmission among MSM living with HIV in France: a modelling approach.
Castry M; Cousien A; Supervie V; Velter A; Ghosn J; Paltiel AD; Yazdanpanah Y; Deuffic-Burban S
Gut; 2021 Aug; 70(8):1561-1569. PubMed ID: 33109688
[TBL] [Abstract][Full Text] [Related]
27. Trends in hepatitis C virus seroprevalence and associated risk factors among men who have sex with men in Montréal: results from three cross-sectional studies (2005, 2009, 2018).
Lanièce Delaunay C; Cox J; Klein M; Lambert G; Grace D; Lachowsky NJ; Maheu-Giroux M
Sex Transm Infect; 2021 Jun; 97(4):290-296. PubMed ID: 32703845
[TBL] [Abstract][Full Text] [Related]
28. Seroprevalence of hepatitis C and correlates of seropositivity among men who have sex with men in Vancouver, Canada: a cross-sectional survey.
Wong J; Moore D; Kanters S; Buxton J; Robert W; Gustafson R; Hogg R; Ogunnaike-Cooke S; Wong T; Gilbert M;
Sex Transm Infect; 2015 Sep; 91(6):430-3. PubMed ID: 25872512
[TBL] [Abstract][Full Text] [Related]
29. Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis.
Solomon SS; McFall AM; Lucas GM; Srikrishnan AK; Kumar MS; Anand S; Quinn TC; Celentano DD; Mehta SH
PLoS Med; 2017 Nov; 14(11):e1002460. PubMed ID: 29182638
[TBL] [Abstract][Full Text] [Related]
30. A Comparison of Men Who Have Sex with Men, People Who Inject Drugs and High-Risk Heterosexuals' Risk for HIV Infection, San Francisco.
Raymond HF; Ick TO; Chen YH
AIDS Behav; 2016 Feb; 20(2):417-22. PubMed ID: 26334446
[TBL] [Abstract][Full Text] [Related]
31. HIV/AIDS among men who have sex with men and inject drugs--United States, 1985-1998.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Jun; 49(21):465-70. PubMed ID: 10882293
[TBL] [Abstract][Full Text] [Related]
32. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.
Horyniak D; Wagner KD; Armenta RF; Cuevas-Mota J; Hendrickson E; Garfein RS
Int J Drug Policy; 2017 Sep; 47():9-17. PubMed ID: 28683432
[TBL] [Abstract][Full Text] [Related]
33. Sustained Effect on Hepatitis C Elimination Among Men Who Have Sex With Men in the Swiss HIV Cohort Study: A Systematic Re-Screening for Hepatitis C RNA Two Years Following a Nation-Wide Elimination Program.
Kusejko K; Salazar-Vizcaya L; Shah C; Stöckle M; Béguelin C; Schmid P; Ongaro M; Darling K; Bernasconi E; Rauch A; Kouyos RD; Günthard HF; Böni J; Fehr JS; Braun DL;
Clin Infect Dis; 2022 Nov; 75(10):1723-1731. PubMed ID: 35404384
[TBL] [Abstract][Full Text] [Related]
34. Low Hepatitis C Virus Prevalence among Men Who Have Sex with Men Attending Public Health Services in The Netherlands.
Popping S; Haspels S; Gotz HM; van der Meijden WCJPM; van den Elshout M; Rijnders BJ
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140558
[TBL] [Abstract][Full Text] [Related]
35. Microelimination or Not? The Changing Epidemiology of Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in France 2012-2018.
Cotte L; Hocqueloux L; Lefebvre M; Pradat P; Bani-Sadr F; Huleux T; Poizot-Martin I; Pugliese P; Rey D; Cabié A;
Clin Infect Dis; 2021 Nov; 73(9):e3266-e3274. PubMed ID: 33400777
[TBL] [Abstract][Full Text] [Related]
36. Modeling the impact of the COVID-19 pandemic on achieving HCV elimination amongst young and unstably housed people who inject drugs in San Francisco.
Fraser H; Stone J; Facente SN; Artenie A; Patel S; Wilson EC; McFarland W; Page K; Vickerman P; Morris MD
Int J Drug Policy; 2024 Jun; ():104452. PubMed ID: 38910096
[TBL] [Abstract][Full Text] [Related]
37. Commercial sex work and risk of HIV infection among young drug-injecting men who have sex with men in San Francisco.
Bacon O; Lum P; Hahn J; Evans J; Davidson P; Moss A; Page-Shafer K
Sex Transm Dis; 2006 Apr; 33(4):228-34. PubMed ID: 16565643
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of the viral hepatitis-HIV syndemic in San Francisco: a collaborative surveillance approach.
Sanchez MA; Scheer S; Shallow S; Pipkin S; Huang S
Public Health Rep; 2014; 129 Suppl 1(Suppl 1):95-101. PubMed ID: 24385655
[TBL] [Abstract][Full Text] [Related]
39. Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review.
Hajarizadeh B; Kairouz A; Ottaviano S; Ireland J; Willing A; Cunningham E; Webb P; Colledge-Frisby S; Wheeler A; Leung J; Tran LT; Price O; Vickerman P; Farrell M; Hickman M; Dore GJ; Bergenström A; Degenhardt L; Grebely J
Lancet Glob Health; 2023 Dec; 11(12):e1885-e1898. PubMed ID: 37973339
[TBL] [Abstract][Full Text] [Related]
40. Public health interventions, priority populations, and the impact of COVID-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): A modeling study.
Lanièce Delaunay C; Klein MB; Godin A; Cox J; Kronfli N; Lebouché B; Doyle C; Maheu-Giroux M
Int J Drug Policy; 2023 Jun; 116():104026. PubMed ID: 37075626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
